How we’re commercialising a pioneering cancer drug

In advance of industry conference BIO-Europe, Henry French speaks to the Enterprise Unit’s Dr Toby Richardson about one of the most promising commercialisation opportunities in our partnering portfolio.
Institute of Cancer Research